These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 2471199)

  • 21. Protection of a T-cell line from human immunodeficiency virus replication by the stable expression of a short antisense RNA sequence carried by a shuttle RNA molecule.
    Cagnon L; Cucchiarini M; Lefebvre JC; Doglio A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Aug; 9(4):349-58. PubMed ID: 7541291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of naturally occurring antisense RNA inhibits human immunodeficiency virus type 1 heterologous strain replication.
    Tagieva NE; Vaquero C
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2503-11. PubMed ID: 9349471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity.
    Kuwasaki T; Hosono K; Takai K; Ushijima K; Nakashima H; Saito T; Yamamoto N; Takaku H
    Biochem Biophys Res Commun; 1996 Nov; 228(2):623-31. PubMed ID: 8920960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The herpes simplex virus 1 Us11 protein cooperates with suboptimal amounts of human immunodeficiency virus type 1 (HIV-1) Rev protein to rescue HIV-1 production.
    Duc Dodon M; Mikaélian I; Sergeant A; Gazzolo L
    Virology; 2000 Apr; 270(1):43-53. PubMed ID: 10772978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro.
    Daly TJ; Cook KS; Gray GS; Maione TE; Rusche JR
    Nature; 1989 Dec; 342(6251):816-9. PubMed ID: 2481237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonviral and viral delivery of a human immunodeficiency virus protective gene into primary human T cells.
    Woffendin C; Yang ZY; Udaykumar ; Xu L; Yang NS; Sheehy MJ; Nabel GJ
    Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11581-5. PubMed ID: 7972106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages.
    Robert-Guroff M; Popovic M; Gartner S; Markham P; Gallo RC; Reitz MS
    J Virol; 1990 Jul; 64(7):3391-8. PubMed ID: 2191150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of intronic and exonic locations of the human immunodeficiency virus type 1 Rev-responsive element.
    Campbell LH; Borg KT; Arrigo SJ
    Virology; 1996 May; 219(2):423-31. PubMed ID: 8638408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional comparison of the Rev trans-activators encoded by different primate immunodeficiency virus species.
    Malim MH; Böhnlein S; Fenrick R; Le SY; Maizel JV; Cullen BR
    Proc Natl Acad Sci U S A; 1989 Nov; 86(21):8222-6. PubMed ID: 2682638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of trans-dominant mutants of the HIV type 1 Rev protein for their ability to inhibit Rev function, HIV type 1 replication, and their use as anti-HIV gene therapeutics.
    Ragheb JA; Bressler P; Daucher M; Chiang L; Chuah MK; VandenDriessche T; Morgan RA
    AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1343-53. PubMed ID: 8573391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antisense oligonucleotides in solution or encapsulated in immunoliposomes inhibit replication of HIV-1 by several different mechanisms.
    Zelphati O; Imbach JL; Signoret N; Zon G; Rayner B; Leserman L
    Nucleic Acids Res; 1994 Oct; 22(20):4307-14. PubMed ID: 7524038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antisense phosphorothioate oligodeoxynucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophages.
    Balotta C; Lusso P; Crowley R; Gallo RC; Franchini G
    J Virol; 1993 Jul; 67(7):4409-14. PubMed ID: 8510229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV Rev-dependent binding of SF2/ASF to the Rev response element: possible role in Rev-mediated inhibition of HIV RNA splicing.
    Powell DM; Amaral MC; Wu JY; Maniatis T; Greene WC
    Proc Natl Acad Sci U S A; 1997 Feb; 94(3):973-8. PubMed ID: 9023367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region.
    Hadzopoulou-Cladaras M; Felber BK; Cladaras C; Athanassopoulos A; Tse A; Pavlakis GN
    J Virol; 1989 Mar; 63(3):1265-74. PubMed ID: 2783738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amplification of antibody production by phosphorothioate oligodeoxynucleotides.
    Branda RF; Moore AL; Lafayette AR; Mathews L; Hong R; Zon G; Brown T; McCormack JJ
    J Lab Clin Med; 1996 Sep; 128(3):329-38. PubMed ID: 8783641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production and characterization of high-titer stocks of rev-defective HIV-1.
    Riggs NL; Guatelli JC
    Virology; 1996 Mar; 217(2):602-6. PubMed ID: 8610453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The multiple inhibitory mechanisms of GEM 91, a gag antisense phosphorothioate oligonucleotide, for human immunodeficiency virus type 1.
    Yamaguchi K; Papp B; Zhang D; Ali AN; Agrawal S; Byrn RA
    AIDS Res Hum Retroviruses; 1997 May; 13(7):545-54. PubMed ID: 9135872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term treatment of human immunodeficiency virus-infected cells with antisense oligonucleotide phosphorothioates.
    Lisziewicz J; Sun D; Metelev V; Zamecnik P; Gallo RC; Agrawal S
    Proc Natl Acad Sci U S A; 1993 May; 90(9):3860-4. PubMed ID: 8483903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of bovine immunodeficiency virus rev cDNAs and identification and subcellular localization of the Rev protein.
    Oberste MS; Williamson JC; Greenwood JD; Nagashima K; Copeland TD; Gonda MA
    J Virol; 1993 Nov; 67(11):6395-405. PubMed ID: 8411341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A bidirectional SF2/ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression.
    Caputi M; Freund M; Kammler S; Asang C; Schaal H
    J Virol; 2004 Jun; 78(12):6517-26. PubMed ID: 15163745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.